Syra Health Past Earnings Performance
Past criteria checks 0/6
Syra Health's earnings have been declining at an average annual rate of -50.1%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 32.9% per year.
Key information
-50.1%
Earnings growth rate
-33.7%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 32.9% |
| Return on equity | -127.6% |
| Net Margin | -54.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Syra Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 8 | -4 | 5 | 1 |
| 30 Jun 24 | 7 | -4 | 5 | 1 |
| 31 Mar 24 | 6 | -4 | 4 | 1 |
| 31 Dec 23 | 6 | -3 | 4 | 0 |
| 30 Sep 23 | 6 | -3 | 4 | 0 |
| 30 Jun 23 | 6 | -3 | 3 | 0 |
| 31 Mar 23 | 6 | -2 | 3 | 0 |
| 31 Dec 22 | 6 | -2 | 3 | 0 |
| 31 Dec 21 | 1 | 0 | 0 | 0 |
Quality Earnings: SYRA is currently unprofitable.
Growing Profit Margin: SYRA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SYRA is unprofitable, and losses have increased over the past 5 years at a rate of 50.1% per year.
Accelerating Growth: Unable to compare SYRA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SYRA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: SYRA has a negative Return on Equity (-127.61%), as it is currently unprofitable.